Andrey G Zenovich
Overview
Explore the profile of Andrey G Zenovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell A, Satran D, Zenovich A, Campbell K, Espel J, Arndt T, et al.
Am Heart J
. 2008 Nov;
156(6):1217-22.
PMID: 19033023
Background: Enhanced external counterpulsation (EECP) is a noninvasive treatment of patients with refractory angina. The immediate hemodynamic effects of EECP are similar to intra-aortic balloon pump counterpulsation, but EECP's effects...
2.
Zenovich A, Taylor D
Front Biosci
. 2008 May;
13:3621-36.
PMID: 18508460
As coronary artery disease (CAD) continues to be the primary cause of mortality, a more in-depth understanding of pathophysiology and novel treatments are being sought. The past two decades have...
3.
Zenovich A, Taylor D
Perit Dial Int
. 2007 Nov;
27 Suppl 2:S94-103.
PMID: 17556339
The recently discovered therapeutic potential of stem or progenitor cells has initiated development of novel treatments in a number of diseases-treatments that could not only improve patients' quality of life,...
4.
Nelson W, Zenovich A, Ott H, Stolen C, Caron G, Panoskaltsis-Mortari A, et al.
Circ Res
. 2007 Oct;
101(12):1319-27.
PMID: 17947799
There are clinically relevant differences in symptomatology, risk stratification, and efficacy of therapies between men and women with coronary artery disease. Sex-based differences in plaque attenuation after administration of bone...
5.
Taylor D, Zenovich A
Curr Heart Fail Rep
. 2007 Mar;
4(1):3-10.
PMID: 17386179
The increasing longevity of patients with heart failure (HF) and the rise in the incidence of HF has created an urgent need to effectively treat and prevent left ventricular remodeling....
6.
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction
Maron M, Olivotto I, Zenovich A, Link M, Pandian N, Kuvin J, et al.
Circulation
. 2006 Nov;
114(21):2232-9.
PMID: 17088454
Background: Nonobstructive hypertrophic cardiomyopathy (HCM) has been regarded as the predominant hemodynamic form of the disease on the basis of assessment of outflow gradient under resting conditions. We sought to...
7.
Harris K, Spirito P, Maron M, Zenovich A, Formisano F, Lesser J, et al.
Circulation
. 2006 Jul;
114(3):216-25.
PMID: 16831987
Background: End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined. Methods...
8.
Pedersen W, Van Tassel R, Pierce T, Pence D, Monyak D, Kim T, et al.
Catheter Cardiovasc Interv
. 2006 Jul;
68(2):183-92.
PMID: 16810699
Objectives: We wished to determine the feasibility and early safety of external beam radiation therapy (EBRT) used following balloon aortic valvuloplasty (BAV) to prevent restenosis. Background: BAV for calcific aortic...
9.
Song L, DePalma S, Kharlap M, Zenovich A, Cirino A, Mitchell R, et al.
Circulation
. 2006 May;
113(18):2186-92.
PMID: 16651466
Background: Genetic mutations are the most common cause of hypertrophic cardiomyopathy (HCM) and an increasingly recognized cause of dilated cardiomyopathy. Autosomal dominant HCM is caused by mutations in sarcomere proteins;...
10.
Zenovich A, Lesser J, Hanna C, Maron B
Am J Cardiol
. 2006 Mar;
97(7):1109.
PMID: 16563928
Left ventricular apical aneurysms, in absence of coronary artery disease, occur in approximately 1% of patients with hypertrophic cardiomyopathy (HC). Identical twins, age 44 years, are presented with HC and...